Elevance Health, Inc. ELV

396.09 (2.16) (0.54%) as of 25 Sep
Market cap
$86.4B
P/E
17.6×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
13.96 14.40 19.02 20.26 18.75 17.93 16.38 18.50 15.74 15.55
P/S ratio
0.39 0.48 0.66 0.77 0.82 0.66 0.74 0.74 0.66 0.44
P/FCF ratio
24.74 18.78 16.70 16.63 15.53 8.33 15.48 25.88 17.41 14.02
P/Operating CF
934.80 121.07 (38.02) (79.40) 67.59 21.12 58.15 146.40 (45.43) 136.15
P/B ratio
1.78 2.06 2.87 3.32 3.13 2.43 2.43 2.38 2.23 1.50
Price to Tangible BV
17.52 81.02 29.61 73.85 87.95 38.29 30.21 0.00 0.00 0.00
EV/Sales
0.37 0.46 0.59 0.70 0.74 0.57 0.68 0.69 0.59 0.34
EV/EBITDA
7.69 7.79 9.67 10.87 10.16 8.50 9.02 9.06 8.97 4.71
EV/Operating CF
17.32 14.06 12.59 13.11 12.28 6.53 11.70 16.49 12.59 8.91
EV/FCF
23.41 17.94 15.00 15.19 14.12 7.22 14.23 24.10 15.53 10.85
Quick Ratio
1.41 1.32 1.30 1.27 1.33 1.42 1.53 1.46 1.45 1.52
Current Ratio
1.54 1.45 1.44 1.40 1.47 1.55 1.66 1.56 1.55 1.61
Net Debt/EBITDA
(0.44) (0.36) (1.09) (1.03) (1.02) (1.30) (0.79) (0.67) (1.09) (1.38)
Debt/Assets
26.25% 26.41% 22.85% 23.21% 23.35% 23.13% 25.03% 25.24% 26.45% 23.49%
Debt/Equity
0.72 0.75 0.63 0.66 0.63 0.60 0.61 0.63 0.70 0.61
Asset Turnover
1.67 1.57 1.62 1.56 1.51 1.49 1.40 1.30 1.33 1.34
Operating CF/Net income
0.76 0.97 1.35 1.43 1.36 2.34 1.26 1.02 1.09 1.32
Capex/Depreciation
(0.72) (0.90) (0.74) (0.69) (0.83) (0.88) (0.95) (1.07) (0.89) (0.64)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
13.25% 14.80% 15.81% 16.27% 17.77% 14.08% 15.95% 13.63% 14.89% 10.26%
ROA
4.75% 5.30% 5.66% 5.89% 6.69% 5.57% 6.45% 5.28% 5.67% 3.90%
ROIC
12.74% 15.10% 19.57% 20.40% 21.31% 19.60% 16.51% 15.27% 15.50% 19.89%
Return on Tangible Assets
21.25% 25.99% 26.49% 29.12% 30.55% 23.11% 25.80% 24.85% 25.48% 16.47%
Average Days of Receivables
39.49 39.32 38.06 37.40 35.38 32.82 36.39 36.90 35.65 36.84
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 11.29% 11.48% 14.32% 12.82% 15.22% 14.05% 14.80%
Intangible Assets out of Total Assets
0.33 0.35 0.33 0.34 0.36 0.36 0.38 0.41 0.39 0.39
Share Based Compensation of Revenue
0.14% 0.11% 0.17% 0.17% 0.18% 0.23% 0.28% 0.25% 0.19% 0.19%
Graham Net Nets
(0.18) (0.19) (0.08) (0.09) (0.09) (0.10) (0.09) (0.13) (0.13) (0.15)
Graham Number
333.30 320.97 307.57 290.57 287.09 230.96 226.99 187.96 180.96 140.66
Earnings Yield
7.17% 6.94% 5.26% 4.94% 5.33% 5.58% 6.11% 5.41% 6.35% 6.43%
Free Cash Flow Yield
4.04% 5.33% 5.99% 6.01% 6.44% 12.00% 6.46% 3.86% 5.74% 7.13%
Revenue per Share
888.95 763.97 726.32 652.48 568.66 485.91 407.88 356.86 344.32 322.80
Operating CF per Share
19.15 25.07 34.17 35.00 34.31 42.62 23.72 14.83 16.00 12.44
Capex per Share
(4.98) (5.42) (5.49) (4.80) (4.46) (4.07) (4.22) (4.68) (3.02) (2.22)
Free Cash Flow per Share
14.17 19.65 28.68 30.20 29.85 38.54 19.51 10.15 12.98 10.22
Cash per Share
161.23 149.68 154.17 142.88 135.47 122.54 100.28 88.12 95.82 90.54
Shareholders Equity per Share
196.54 178.79 167.04 151.38 148.19 132.37 124.18 110.58 101.35 95.48
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
196.54 178.79 167.04 151.38 148.19 132.37 124.18 110.58 101.35 95.48
Free Cash Flow
3,174.00 4,552.00 6,765.00 7,247.00 7,277.00 9,667.00 4,984.00 2,619.00 3,394.00 2,686.00
Working Capital
21,966.00 18,361.00 18,238.00 15,921.00 16,237.00 16,298.00 15,501.00 12,356.00 12,907.00 13,020.50
Capital Expenditures
(1,116.00) (1,256.00) (1,296.00) (1,152.00) (1,087.00) (1,021.00) (1,077.00) (1,208.00) (791.00) (584.00)
Net Current Asset Value
(14,467.00) (16,521.00) (9,494.00) (10,808.00) (10,210.00) (7,665.00) (6,692.00) (8,709.00) (7,774.00) (5,667.80)
EV/EBIT
9.16 8.98 11.60 13.03 11.66 9.89 10.53 10.82 10.57 5.52
Capex to Sales
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Net Profit Margin
2.84% 3.38% 3.49% 3.76% 4.44% 3.75% 4.61% 4.07% 4.27% 2.91%
Price to Operating Income
9.68 9.40 12.92 14.26 12.82 11.41 11.46 11.62 11.86 7.13
Other line items
Depreciation/Fixed assets
0.33 0.30 0.40 0.39 0.33 0.33 0.36 0.41 0.41 0.46
Cash ROIC
(0.35%) 1.08% 3.68% 4.32% 4.84% 8.58% 3.82% 1.57% 2.86% 2.01%
Accounts Receivable Turnover
9.81 9.58 10.11 10.62 11.36 11.42 10.58 10.17 10.37 10.67
Accounts Payable Turnover
7.20 6.45 6.40 6.53 6.42 6.49 6.51 5.56 5.72 5.78
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
52.59 56.18 59.33 59.68 59.47 63.41 56.81 64.40 66.69 65.93
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
20,306.50 18,468.00 16,954.50 14,742.00 12,199.00 10,674.50 9,851.00 9,052.50 8,680.05 7,953.45
Average Payables
23,539.50 22,847.00 22,112.00 19,845.50 17,670.00 14,946.00 12,862.50 12,942.00 12,635.90 11,553.20
Average Assets
119,191.50 112,908.50 105,841.50 100,107.50 92,037.50 82,034.00 74,512.00 71,055.50 67,811.55 63,400.45
Average Common Equity
42,726.00 40,415.50 37,867.50 36,229.00 34,663.50 32,463.50 30,134.50 27,522.00 25,801.70 24,072.25

Fold the line items

Columns are period end dates